TipRanks
Go Ultimate55% OFF

CStone Pharmaceuticals (2616) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

2616 Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to CStone Pharmaceuticals in the past 3 months

2616 Stock 12 Month Forecast

HKD 9.65▲(95.24% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for CStone Pharmaceuticals in the last 3 months. The average price target is HKD 9.65 with a high forecast of HKD 11.56 and a low forecast of HKD 7.73. The average price target represents a 95.24% change from the last price of HKD 4.94.
Highest Price TargetHKD 11.56Average Price TargetHKD 9.65Lowest Price TargetHKD 7.73

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:2616
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
GF Securities Analyst forecast on HK:2616Unknown AnalystNot RankedGF SecuritiesHKD 11.56buy134.01%UpsideReiterated10/09/26
SDIC Securities Analyst forecast on HK:2616Unknown AnalystNot RankedSDIC SecuritiesHKD 7.73buy56.48%UpsideReiterated09/02/26
Goldman Sachs Analyst forecast on HK:2616Unknown AnalystNot RankedGoldman SachsHKD 8.26→HKD 9.44buy91.09%UpsideReiterated03/30/26
Guoyuan Securities (HK) Analyst forecast on HK:2616Unknown AnalystNot RankedGuoyuan Securities (HK)HKD 10.30buy108.50%UpsideReiterated03/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CStone Pharmaceuticals

3 Months
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/2 ratings generated profit
0%
Average Return
-2.40%

Copying Anthropic Health Care HK's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -2.40% per trade.

1 Year
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/2 ratings generated profit
0%
Average Return
-6.85%

Copying Anthropic Health Care HK's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.85% per trade.

2 Years
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/2 ratings generated profit
0%
Average Return
-6.85%

Copying Anthropic Health Care HK's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.85% per trade.

2616 Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 2616
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00001
Buy00011
Hold00000
Sell00000
Strong Sell00000
total00012

In the current month, 2616 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2616 average Analyst price target in the past 3 months is 9.65.

2616 Financial Forecast

HKD -2HKD -1.5HKD -1HKD -0.5HKD 0Q2 2025Q2 2026Q4 2026
HighHKD -0.14
ConsensusHKD -0.14
LowHKD -0.14

2616 Earnings Forecast

Next quarter’s earnings estimate for 2616 is -HKD 0.14 with a range of -HKD 0.14 to -HKD 0.14. The previous quarter’s EPS was -HKD 0.20. 2616 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2616 has Performed in-line its overall industry.

HKD 53.1MHKD 112MHKD 171MHKD 229.9MHKD 288.8MQ2 2025Q2 2026Q4 2026
HighHKD 289M
ConsensusHKD 289M
LowHKD 289M

2616 Sales Forecast

Next quarter’s sales forecast for 2616 is HKD 288.82M with a range of HKD 288.82M to HKD 288.82M. The previous quarter’s sales results were HKD 233.81M. 2616 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2616 has Performed in-line its overall industry.

2616 Stock Forecast FAQ

What is HK:2616’s average 12-month price target, according to analysts?
Based on analyst ratings, CStone Pharmaceuticals’s 12-month average price target is HK$9.65.
What is HK:2616’s upside potential, based on the analysts’ average price target?
CStone Pharmaceuticals has 95.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CStone Pharmaceuticals a Buy, Sell or Hold?
CStone Pharmaceuticals has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is CStone Pharmaceuticals’s share price target?
The average share price target for CStone Pharmaceuticals is HK$9.65. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$11.56, and the lowest forecast is HK$7.73. The average share price target represents a 95.24% increase from the current price of HK$4.94.
What do analysts say about CStone Pharmaceuticals?
CStone Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of CStone Pharmaceuticals?
To buy shares of HK:2616, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.